Subscribe To
VB / A Bull Market Is Coming: Why Buying These ETFs Is a Smart Move
VB News
By Zacks Investment Research
October 18, 2023
Should Vanguard Small-Cap ETF (VB) Be on Your Investing Radar?
If you're interested in broad exposure to the Small Cap Blend segment of the US equity market, look no further than the Vanguard Small-Cap ETF (VB), a more_horizontal
By Seeking Alpha
October 11, 2023
VB: Small Caps Are A Buy In My View
I evaluate the Vanguard Small-Cap Index Fund ETF as an investment at the current market price. I believe small-caps can benefit from continued US econ more_horizontal
By Seeking Alpha
September 27, 2023
VB: Downside Risk Remains Despite Reasonable Valuation
Vanguard Small-Cap ETF has a portfolio of 1500 small-cap U.S. stocks. VB's valuation is reasonable, but there is still high downside risk, especially more_horizontal
By Seeking Alpha
July 17, 2023
VB: Better Than Large Cap
Small-cap stocks are under pressure due to rising borrowing costs and a weak macroeconomic outlook, but are still beating expectations with 11% YTD re more_horizontal
By Seeking Alpha
July 16, 2023
VB: Changing My Mind On Vanguard's Small-Cap ETF
I decided to sell the VB ETF fund due to its underperformance compared to the S&P 500 and Invesco Nasdaq-100 Trust. Despite its low expense ratio and more_horizontal
By Zacks Investment Research
May 31, 2023
Should Vanguard Small-Cap ETF (VB) Be on Your Investing Radar?
If you're interested in broad exposure to the Small Cap Blend segment of the US equity market, look no further than the Vanguard Small-Cap ETF (VB), a more_horizontal
By Seeking Alpha
April 28, 2023
Stocks Finish April Higher, Impressive Earnings Boost Large Caps, VB Small-Cap ETF Lags
The S&P 500 turned in a modestly positive April, with gains coming in the last few sessions. Small caps, meanwhile, are mired in a stubborn range that more_horizontal
By Investors Business Daily
April 24, 2023
Don't Sleep On This Growth Stock: Soaring Sales Make Up For Inspire's Losses
Growth stock Inspire Medical has strong sales growth since its IPO. The stock is near a buy point with earnings due. more_horizontal